The oral route is the most preferred route for systemic and local drug delivery. However, the
oral drug delivery system faces the harsh physiological and physicochemical environment of …

As nanocarriers (NCs) can improve the solubility of drugs, prevent their degradation by
gastrointestinal (GI) enzymes and promote their transport across the mucus gel layer and …

Nano-drug delivery systems (NDDS) for colon-targeted drug delivery are an active area of
research on local diseases affecting the colon, such as ulcerative colitis, Crohn's disease …

Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis
(UC), is characterized by chronic relapsing inflammation of the gastrointestinal tract. Delivery …

Inflammatory bowel disease (IBD) is a chronic relapsing and remitting inflammatory disorder
of the small intestine and colon. IBD includes ulcerative colitis (UC) and Crohn's disease …

Plant-derived nanovesicles (PDNVs) have recently emerged as natural delivery systems of
biofunctional compounds toward mammalian cells. Considering their already described …

Inflammatory diseases present with dysregulated inflammatory reactions and oxidative
stress, resulting in heavy health-associated economic burden to society. Current mainstream …

Many synthetic drugs and monoclonal antibodies are currently in use to treat Inflammatory
Bowel Disease (IBD). However, they all are implicated in causing severe side effects and …

Curcumin (CUR) is a promising edible phytochemical compound with ideal ulcerative colitis
(UC) treatment activity; however, it is characteristically instable in the digestive tract and has …

Inflammatory bowel disease (IBD) manifests as inflammation in the colon, rectum, and ileum,
presenting a global health concern with increasing prevalence. Therefore, effective anti …